Clinical trial
Efficacy and Safety of Dapagliflozin in Polycystic Ovary Syndrome: a Multicentre, Randomized, Placebo-controlled Trial
NCT04213677 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Dapagliflozin in Polycystic Ovary Syndrome: a Multicentre, Randomized, Placebo-controlled Trial
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 20, 2020
- Completion date
- November 1, 2022
- Enrollment
- 165 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.